淋病奈瑟菌中抗生素耐药性的适应代价和益处：需要多学科方法。
Fitness cost and benefit of antimicrobial resistance in Neisseria gonorrhoeae: Multidisciplinary approaches are needed.
机构信息
WHO Collaborating Centre for Gonorrhoea and other STIs, Department of Laboratory Medicine, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
出版信息
PLoS Med. 2017 Oct 31;14(10):e1002423. doi: 10.1371/journal.pmed.1002423. eCollection 2017 Oct.
Abstract
In a Perspective on the research article by Didelot and colleagues, Magnus Unemo and Christian Althaus discuss the value of modelling studies to inform antimicrobial resistance management and the limitations of the current evidence base informing such models.
摘要
在对 Didelot 及其同事的研究文章的观点中，Magnus Unemo 和 Christian Althaus 讨论了建模研究在为抗菌药物耐药性管理提供信息方面的价值，以及当前为这类模型提供信息的证据基础的局限性。
相似文献
1
Fitness cost and benefit of antimicrobial resistance in Neisseria gonorrhoeae: Multidisciplinary approaches are needed.淋病奈瑟菌中抗生素耐药性的适应代价和益处：需要多学科方法。
PLoS Med. 2017 Oct 31;14(10):e1002423. doi: 10.1371/journal.pmed.1002423. eCollection 2017 Oct.
2
Prevalence of Cefixime-Resistant Neisseria gonorrhoeae in Melbourne, Australia, 2021-2022.2021-2022 年澳大利亚墨尔本头孢克肟耐药淋病奈瑟菌的流行情况。
J Infect Dis. 2024 Nov 15;230(5):e1121-e1125. doi: 10.1093/infdis/jiae313.
3
Trends in antimicrobial resistance in Neisseria gonorrhoeae in Hanoi, Vietnam, 2017-2019.2017-2019 年越南河内淋病奈瑟菌的抗生素耐药趋势。
BMC Infect Dis. 2020 Nov 5;20(1):809. doi: 10.1186/s12879-020-05532-3.
4
Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014.淋病奈瑟菌抗菌药物敏感性监测 - 淋球菌分离株监测项目，美国 27 个监测点，2014 年。
MMWR Surveill Summ. 2016 Jul 15;65(7):1-19. doi: 10.15585/mmwr.ss6507a1.
5
Overall Low Extended-Spectrum Cephalosporin Resistance but high Azithromycin Resistance in Neisseria gonorrhoeae in 24 European Countries, 2015.2015年24个欧洲国家淋病奈瑟菌对广谱头孢菌素的总体耐药率较低，但对阿奇霉素的耐药率较高。
BMC Infect Dis. 2017 Sep 11;17(1):617. doi: 10.1186/s12879-017-2707-z.
6
Decline in Decreased Cephalosporin Susceptibility and Increase in Azithromycin Resistance in Neisseria gonorrhoeae, Canada.加拿大淋病奈瑟菌对头孢菌素敏感性下降及对阿奇霉素耐药性增加
Emerg Infect Dis. 2016 Jan;22(1):65-7. doi: 10.3201/eid2201.151247.
7
Changes in the six most common sequence types of Neisseria gonorrhoeae, including ST4378, identified by surveillance of antimicrobial resistance in northern Taiwan from 2006 to 2013.2006 年至 2013 年台湾北部地区抗菌药物耐药性监测发现淋病奈瑟菌六种主要流行株（包括 ST4378）的变化。
J Microbiol Immunol Infect. 2016 Oct;49(5):708-716. doi: 10.1016/j.jmii.2014.08.016. Epub 2014 Nov 1.
8
External quality assessment (EQA) of Neisseria gonorrhoeae antimicrobial susceptibility testing in primary laboratories in Germany.德国基层实验室淋病奈瑟菌抗菌药物敏感性检测的外部质量评估。
BMC Infect Dis. 2020 Jul 16;20(1):514. doi: 10.1186/s12879-020-05234-w.
9
The European gonococcal antimicrobial surveillance programme (Euro-GASP) appropriately reflects the antimicrobial resistance situation for Neisseria gonorrhoeae in the European Union/European Economic Area.欧洲淋球菌抗菌药物监测计划（Euro-GASP）恰当地反映了欧盟/欧洲经济区淋病奈瑟菌的抗菌药物耐药情况。
BMC Infect Dis. 2019 Dec 10;19(1):1040. doi: 10.1186/s12879-019-4631-x.
10
Neisseria gonorrhoeae Resistant to Ceftriaxone and Cefixime, Argentina.阿根廷发现对头孢曲松和头孢克肟耐药的淋病奈瑟菌
Emerg Infect Dis. 2016 Jun;22(6):1139-41. doi: 10.3201/eid2206.152091.
引用本文的文献
1
Molecular epidemiological typing of isolates identifies a novel association between genogroup G10557 (G7072) and decreased susceptibility to cefixime, Germany, 2014 to 2017.对 分离株的分子流行病学分型确定了 2014 年至 2017 年德国 G10557（G7072）基因群与头孢克肟敏感性降低之间的新关联。
Euro Surveill. 2020 Oct;25(41). doi: 10.2807/1560-7917.ES.2020.25.41.1900648.
2
Summary and Trends of the Russian Gonococcal Antimicrobial Surveillance Programme, 2005 to 2016.俄罗斯淋球菌抗菌药物监测计划概要及趋势，2005 年至 2016 年。
J Clin Microbiol. 2019 May 24;57(6). doi: 10.1128/JCM.02024-18. Print 2019 Jun.
3
Moving Forward With Treatment of Gonorrhea for Users of Human Immunodeficiency Virus Preexposure Prophylaxis Given the Threat of Antimicrobial Resistance.鉴于抗菌药物耐药性的威胁，推进针对接受人类免疫缺陷病毒暴露前预防的使用者的淋病治疗
Clin Infect Dis. 2018 Jun 18;67(1):155-156. doi: 10.1093/cid/ciy050.
4
Sexually transmitted infections-Research priorities for new challenges.性传播感染-应对新挑战的研究重点。
PLoS Med. 2017 Dec 27;14(12):e1002481. doi: 10.1371/journal.pmed.1002481. eCollection 2017 Dec.
本文引用的文献
1
Estimating the fitness cost and benefit of cefixime resistance in Neisseria gonorrhoeae to inform prescription policy: A modelling study.评估淋病奈瑟菌中头孢克肟耐药性的适应性成本和益处以指导处方政策：一项建模研究。
PLoS Med. 2017 Oct 31;14(10):e1002416. doi: 10.1371/journal.pmed.1002416. eCollection 2017 Oct.
2
Impact of Rapid Susceptibility Testing and Antibiotic Selection Strategy on the Emergence and Spread of Antibiotic Resistance in Gonorrhea.快速药敏试验和抗生素选择策略对淋病中抗生素耐药性出现和传播的影响
J Infect Dis. 2017 Nov 27;216(9):1141-1149. doi: 10.1093/infdis/jix450.
3
Overall Low Extended-Spectrum Cephalosporin Resistance but high Azithromycin Resistance in Neisseria gonorrhoeae in 24 European Countries, 2015.2015年24个欧洲国家淋病奈瑟菌对广谱头孢菌素的总体耐药率较低，但对阿奇霉素的耐药率较高。
BMC Infect Dis. 2017 Sep 11;17(1):617. doi: 10.1186/s12879-017-2707-z.
4
Multidrug-resistant gonorrhea: A research and development roadmap to discover new medicines.多重耐药性淋病：发现新药的研发路线图。
PLoS Med. 2017 Jul 26;14(7):e1002366. doi: 10.1371/journal.pmed.1002366. eCollection 2017 Jul.
5
Sexually transmitted infections: challenges ahead.性传播感染：未来的挑战。
Lancet Infect Dis. 2017 Aug;17(8):e235-e279. doi: 10.1016/S1473-3099(17)30310-9. Epub 2017 Jul 9.
6
Antimicrobial resistance in Neisseria gonorrhoeae: Global surveillance and a call for international collaborative action.淋病奈瑟菌的抗菌药物耐药性：全球监测及国际合作行动呼吁
PLoS Med. 2017 Jul 7;14(7):e1002344. doi: 10.1371/journal.pmed.1002344. eCollection 2017 Jul.
7
Antimicrobial Susceptibility of Neisseria gonorrhoeae in Japan from 2000 to 2015.2000年至2015年日本淋病奈瑟菌的抗菌药物敏感性
Sex Transm Dis. 2017 Mar;44(3):149-153. doi: 10.1097/OLQ.0000000000000556.
8
Antibiotic-Resistant Neisseria gonorrhoeae Spread Faster with More Treatment, Not More Sexual Partners.耐抗生素淋病奈瑟菌通过更多治疗而非更多性伴侣传播得更快。
PLoS Pathog. 2016 May 19;12(5):e1005611. doi: 10.1371/journal.ppat.1005611. eCollection 2016 May.
9
Emergence and evolution of internationally disseminated cephalosporin-resistant Neisseria gonorrhoeae clones from 1995 to 2005 in Japan.1995年至2005年期间日本国际传播的耐头孢菌素淋病奈瑟菌克隆的出现与演变
BMC Infect Dis. 2015 Sep 17;15:378. doi: 10.1186/s12879-015-1110-x.
10
Current and future antimicrobial treatment of gonorrhoea - the rapidly evolving Neisseria gonorrhoeae continues to challenge.淋病的当前及未来抗菌治疗——不断快速演变的淋病奈瑟菌持续构成挑战。
BMC Infect Dis. 2015 Aug 21;15:364. doi: 10.1186/s12879-015-1029-2.
Zotero 插件